Interaction between grapefruit juice and diazepam in humans
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bailey D.G., Spence J.D., Munoz C., Amold J.M.O. (1991): Interaction of citrus grapefruit juice with felodipine and nifedipine. Lancet, 337, 268–269.
Bailey D.G., Arnold J.M.O., Munoz C., Spence J.D. (1993): Grapefruit juice-felodipine interaction: mechanism predictability and effect of naringin. Clin. Pharmacol. Ther., 53, 637–642.
Edgar B., Bailey D.G., Bergstrand R., Johnsson G., Regardh C.G. (1992): Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine and its potential clinical relevance. Eur. J. Clin. Pharmacol., 42, 313–317.
Rashid T.J., Martin U., Clarke H., Waller D.G., Renwick A.G., George C.F. (1995): Factors affecting the absolute bioavailability of nifedipine. Br. J. Clin. Pharmacol., 40, 51–58.
Siguch H., Hippius M., Henschel L., Kaufmann K., Hoffmann A. (1994): Influence of grapefruit juice on the pharmacokinetics of a slow release nifedipine formulation. Pharmazie, 49, 522–524.
Soons P.A., Voggels B.A.P.M., Roosemalen M.C.M. et al. (1991): Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans. Clin. Pharmacol. Ther., 50, 394–403.
Bailey D.G., Arnold J.M.O., Strong H.A., Munoz C., Spence J.D. (1993): Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin. Pharmacol. Ther., 54, 589–594.
Benton R.E., Honig H.K., Zamani K., Cantilena L.R., Woosley L.R. (1996): Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram. Clin. Pharmacol. Ther., 59, 383–388.
Ducharme M.P., Warbasse L.H., Edwards D.J. (1995): Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin. Pharmacol. Ther., 57, 485–491.
Hollande A.A., Van Roois J. Lendjes G.V. et al. (1995): The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients. Clin. Pharmacol. Ther., 57, 318–324.
Kupperschmidt H.H.T., Ha R.H., Ziegler W.H., Meier P.S., Krahenbühl S. (1995): Interaction between grapefruit juice and midazolam in humans. Clin. Pharmacol. Ther., 58, 20–28.
Ha R.H., Chen J., Leuenberger P.M., Freiburghaus A.U., Follath F. (1995): In vitro inhibition of midazolam and quinidine metabolism by flavonoids. Eur. J. Clin. Pharmacol., 48, 367–371.
Hukkien S.K., Varhe A., Olkkola K., Neuvonen P.J. (1995): Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clin. Pharmacol. Ther., 58, 127–131.
Nemeroff C.B., De Vane C.L., Pollock B.G. (1996): Newer antidepressants and the cytochrome P450 system. Am. J. Psychiatry, 153, 311–320.
Guengerich F.P., Brian W.R., Iwasaki M., Sari M.A., Baarnhelm C., Berntsson P. (1991): Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P450IIIA4. J. Med. Chem., 34, 1838–1844.
Miniscalco A., Lundahl J., Regardh C., Edgar B., Eriksson G. (1992): Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J. Pharmacol. Exp. Ther., 261, 1195–1199.
Fuhr U., Klittich K., Staib A.H. (1993): Inhibitory effect of grapefruit juice its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br. J. Clin. Pharmacol. 35, 431–436.
Merkel U., Sigusch H., Hoffmann A. (1994): Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers. Eur. J. Clin. Pharmacol., 46, 175–177.
Guengerich F.P., Shimada T., Yun C.H. et al. (1994): Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1 and 3A4 enzymes. Environ. Health Perspect., 9, 49–53.
De, Waziers, I., Cugnene P.H., Yang C.S., Leroux J.P., Baune P.H. (1990): Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J. Pharmacol. Exp. Ther., 253, 387–394.
Kronbach T., Mathyse D., Umeno M., Gonzales F.J., Meyer U.A. (1989): Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol. Pharmacol., 36, 89–96.
Fuhr U., Kummert, L.A. (1995): The fate of naringin in humans: a key to grapefruit juice-drug interactions. Clin. Pharmacol. Ther., 58, 365–373.
Guengerich F.P., Kim H.D. (1990): In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis, 11, 2275–2279.
Cresteil T., Monsarrat B., Alvinerie P., Treluyer J.M., Vieira I., Wright M. (1994): Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation. Cancer Res., 54, 386–392.